Arkolith/Insider Trading/ATRA/Form 4

Nguyen AnhCo

EVP, Chief Sci. & Tech OfficerAtara Biotherapeutics, Inc. (ATRA) · full profile →Form 4 · filed Mar 6, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$8K
Net Open-Market Flow
-$8K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2024Sell(S)11K$0.72$8K941K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-24-000910) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML